| Literature DB >> 32599489 |
Chee-Leong Kee1, Xiaowei Ge2, Cao-Son Tran3, Quang-Dong Bui3, Nuan-Ping Cheah2, Min-Yong Low2.
Abstract
A new phosphodiesterase type-5 inhibitor (PDE-5i) with thiocarbonyl and thiolactam skeleton has been identified. The unknown compound has very similar properties like dithio-desmethyl carbodenafil, which was detected alongside during the screening process. It has been isolated by a semi-preparative high performance liquid chromatography tandem ultra-violet detector (HPLC-UV). The purified compound has been characterized using Fourier-transform infrared spectroscopy (FTIR), high-resolution mass spectrometry (HRMS) and nuclear magnetic resonance spectroscopy (NMR). It is named as N-hydroxyethyl dithio-desethyl carbodenafil due to attachment of a hydroxyethyl group to the heterocyclic nitrogen of dithio-desethyl carbodenafil.Entities:
Keywords: FTIR; HRMS; Health supplement; N-Hydroxyethyl dithio-desethyl carbodenafil; NMR
Mesh:
Substances:
Year: 2020 PMID: 32599489 DOI: 10.1016/j.jpba.2020.113431
Source DB: PubMed Journal: J Pharm Biomed Anal ISSN: 0731-7085 Impact factor: 3.935